Device Cardiology

Visitag Surpoint External Processing Unit

Payments companies reported to CMS as associated with Visitag Surpoint External Processing Unit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,801associated payments (2023-2025)
94clinicians with associated payments
1company reporting

By year

2023 $3,208
2024 $771
2025 $822

Payments reported as associated with Visitag Surpoint External Processing Unit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $2,762
Cardiovascular Disease $743
Internal Medicine $726
Family $127
Anesthesiology $74.18
Interventional Cardiology $47.30

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Visitag Surpoint External Processing Unit

These are the largest totals companies reported as associated with Visitag Surpoint External Processing Unit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Claudio Bonometti Las Vegas, NV Clinical Cardiac Electrophysiology $358.03
Amaan Shafi Las Vegas, NV Internal Medicine $146.46
Ali Namazi Las Vegas, NV Cardiovascular Disease $146.46
Kachon Lei Las Vegas, NV Internal Medicine $146.46
Awad Javaid Las Vegas, NV Internal Medicine $146.46
Chowdhury Ahsan Las Vegas, NV Cardiovascular Disease $146.46
Arjun Gururaj Las Vegas, NV Cardiovascular Disease $141.76
Erik Sirulnick Las Vegas, NV Clinical Cardiac Electrophysiology $133.85
Daniel Nelson Appleton, WI Clinical Cardiac Electrophysiology $127.11
Bryce Yantis Mattoon, IL Family $127.01

Prescribed Visitag Surpoint External Processing Unit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.